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ABSTRACT
Background
In recent years, there has been an increase in prescription drug abuse, particularly among
adolescents and young adults. While substance abuse on college campuses has remained a
pervasive public health concern, rates of nonmedical prescription drug use surpass commonly
abused drugs. The three most commonly abused prescription drugs (central nervous system
(CNS) depressants, opioids, and stimulants) were assessed to identify differences among student
characteristics, as well as their relationship with abuse.
Purpose
The purpose of this study is to conduct a secondary analysis to explore demographic variables
(race, gender, academic performance, living arrangement, alcohol and other drug usage, and
affiliation with a fraternity/sorority) and their relationship with nonmedical prescription drug use.
Also, this study aims to identify potential strategies and provide suggestions to address
nonmedical prescription drug abuse for future interventions.
Methods
Data was obtained from the 2009 National College Health Assessment. The study consisted of n
= 1,417 undergraduate students attending Virginia Commonwealth University. Initially, overall
prevalence rates for past-year illicit use of prescription CNS depressant, opioids, and stimulant
use were examined. Bivariate analyses were conducted to identify differences among users and
nonusers for each class of prescription drug using Pearson’s Chi-Square test of significance.
Multiple logistic regressions were used to examine associations between these demographics and
illicit use of each prescription drug. Interactions between individual demographics and drug use
were also examined.
Results
The past year prevalence use of nonmedical prescription central nervous system depressants,
opioids, and stimulants use were 4, 11.2, and 8.7% respectively. According to bivariate
analyses, nonmedical use was higher among certain college students, however characteristics
varied by type of prescription drug. Multiple logistic regression analyses indicated that students
living off campus (OR = 2.12, 95% CI = 1.03, 4.35) and reported use of alcohol (OR = 3.91,
95% CI = 1.21, 12.64) and marijuana (OR = 4.41, 95% CI = 2.28, 8.54) were more likely to use
prescription depressants. Students with a GPA of a C or lower (OR = 1.50, 95% CI = 1.03,
2.17), and reported use of marijuana (OR = 3.25, 95% CI = 2.22, 4.78) were more likely to use
prescription opioids. Nonmedical prescription stimulant use was highest among White students
(OR = 2.02, 95% CI = 1.28, 3.30) with a GPA of a B or lower (OR = 2.06, 95% CI = 1.28, 3.30)
and reported lifetime use of alcohol (OR = 7.96, 95% CI = (2.50, 25.41).
Conclusions
The results of this study provide insight into the demographic variables and their relationship
with nonmedical prescription drug abuse. The findings have important implications for
identifying potential strategies to address nonmedical prescription drug abuse and will assist in
the development of targeted and tailored interventions.
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INTRODUCTION
The abuse of alcohol and drugs on college campuses remains a pervasive public health
concern. While alcohol and cigarettes have shown significant changes in use throughout the
intervening decades, many new illicit drugs have emerged, including the use of nonmedical
prescription drugs (Johnston, O'Malley, Bachman, & Schulenberg, 2009). Nonmedical use of
prescription drugs is defined as use without a legitimate prescription or inconsistent with a
doctor’s instructions (Hamilton, 2009). An estimated 48 million people (ages 12 and older) have
used prescription drugs for nonmedical reasons in their lifetime, constituting roughly 20% of the
U.S. population (Volkow, 2009). In a single survey, first-time nonmedical use of pain relievers
was reported by 2.2 million people aged 12 years or older (Hamilton, 2009). Between 1992 and
2003, the use of nonmedical prescription drugs among 12 to 17 year olds increased 212% (Ford
& Schroeder, 2008). This issue has received significant public health attention during the past
15 years and has developed into a concerning trend among college students (Garnier, O’Grady,
& Wish, 2009).
The annual prevalence of nonmedical use of any prescription drug (i.e., stimulants,
opioids, sedatives, or tranquilizers) among U.S. college students increased from 8.3% in 1996 to
14.6% in 2006. Over the same time period, the prevalence of marijuana declined, indicating a
shift in drug abuse among students (McCabe, 2007). The three classes of prescription drugs that
are most commonly abused are central nervous system (CNS) depressants, opioids, and
stimulants (National Institute on Drug Abuse [NIDA], 2009). The safety of these prescription
medications is often misconstrued as they are known for their therapeutic benefits, however they
are extremely addictive and misuse can result in serious health consequences (Hamilton, 2009;
NIDA, 2009).
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Commonly Abused Prescription Drugs
CNS depressants are used to treat anxiety and sleep disorders. Commonly prescribed
depressants include Amytal, Valium, and Xanax. Side effects include impaired coordination and
dizziness however, when used at unprescribed rates, or combined with other substances that
depress functioning, including alcohol, heart rate and respiration can slow down dangerously.
Abuse of these medications can result in cardiac arrest and potentially death (NIDA, 2009).
Opioids, also known as prescription narcotics or pain killers, are prescribed for their
effective pain-relieving qualities. Commonly prescribed opioids include OxyContin, Percodan,
and Percocet. Opioids are highly addictive and side effects include drowsiness, nausea,
constipation, and, depending upon the amount taken, depressed respiration (NIDA, 2009).
Opioids also have dangerous combination effects, particularly when consumed with alcohol,
which increases respiratory distress (NIDA, 2009).
The third most commonly abused class of prescription drugs are stimulants which are
often used to prescribe certain sleep disorders and attention deficit hyperactivity disorder
(ADHD). Common stimulants such as Ritalin and Adderall, are mistakenly perceived as safe,
and are used nonmedically to improve academic performance or cause weight loss (Hamilton,
2009). However, taken repeatedly or in high doses, stimulants can cause anxiety, paranoia,
dangerously high body temperatures, irregular heartbeat, or seizures (NIDA, 2009).
As awareness of their side effects and access has increased, prescription drugs have
become a significant public health concern. Students are not only using these drugs for
recreational purposes, but also to help with concentration when cramming for papers or tests, to
self-medicate for anxiety or depression, and even to enhance their stamina when playing sports
(Higher Education Center for Alcohol, Drug Abuse, and Violence Prevention, 2010). It is
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critical that health professionals understand the risk factors associated with nonmedical
prescription drug use to correct student’s misperceptions and reduce use on college campuses
(Hamilton, 2009; McCabe, 2008).
The purpose of this study is to identify risk factors for nonmedical prescription CNS
depressant, opioid, and stimulant use among college students to create effective health
interventions to reduce abuse on campus. Prescription drug abuse is a growing concern,
therefore information regarding race, gender, academic performance (measured by grade point
average, GPA), living arrangement, alcohol and other drug usage, and affiliation with a
fraternity/sorority will assist health professionals in addressing this public health issue. This
research will identify student characteristics that are associated with increased likeliness of abuse
and offer strategies for the creation of effective interventions.
Specific Aims:
o

Explore the demographic variables (race, gender, academic performance, living
arrangement, alcohol and other drug usage, and affiliation with a fraternity/sorority)
associated with nonmedical prescription drug use.

o

Explore the relationship between race, gender, academic performance, living
arrangement, alcohol and other drug usage, and/or affiliation with a fraternity/sorority
and nonmedical prescription drug use.

o

Identify potential strategies and provide suggestions to address nonmedical
prescription drug abuse for tailored and targeted interventions.
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LITERATURE REVIEW
Prescription medications provide invaluable relief to countless people with health
problems, and when taken appropriately can improve the quality and length of life (NIDA,
2009). Regrettably, the nonmedical use of prescription drugs is a serious and growing public
health problem in this country, especially among college students (Ford & Schroeder, 2008;
Hamilton, 2009; Garnier et al., 2009). The College Alcohol Study reported significant increases
in the prevalence of nonmedical prescription drug use between 1993 and 2001 across several
types of prescription medication (Ford & Schroeder, 2008). Furthermore, a comparison of
survey summaries between 2002 and 2005 revealed an increase in intentional abuse of
prescription medications among college students from 5.4% to 6.3% (Hamilton, 2009). Current
past-year use estimates among college students range from 7% to 9%, with lifetime use ranging
between 12% and 14% (Garnier et al., 2009).
The National Institute on Drug Abuse’s categories of prescription drugs with potential for
abuse includes dissociative anesthetics, opioids and morphine derivatives, stimulants, anabolic
steroids, tranquilizers, sedative-hypnotics, and muscle relaxers. These drugs are generally
recognized as addictive, with the potential for users to develop tolerance to the medication, as
well as withdrawal syndrome (Hamilton, 2009). The three classes of prescription drugs that are
most commonly abused are central nervous system (CNS) depressants, opioids, and stimulants
(NIDA, 2009). The annual prevalence of nonmedical use of any type of prescription drug in the
general population (individuals aged 18 to 25) is 15.5%. Reflecting national trends, the annual
prevalence of use among U.S. college students increased from 8.3% in 1996 to 14.6% in 2006
(McCabe, 2008). Specifically, the prevalence rate for illicit use within the past year among
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college students was highest for pain medication, followed by stimulant medication, sedative or
anxiety medication, and sleeping medication (McCabe, Teter, & Boyd, 2006).
CNS Depressants
Central Nervous System (CNS) depressants are medications that slow brain function. In
higher doses, some CNS depressants, including tranquilizers and sedatives, can be used as
general anesthetics or preanesthetics. Based on their chemistry and pharmacology, CNS
depressants are divided into three categories: barbiturates, benzodiazepines, and newer sleep
medications (NIDA, 2009). Barbiturates, such as mephobarbital (Mebaral) and sodium
pentobarbital (Nembutal), are used as preanesthetics, promoting sleep. Benzodiazepines, such as
diazepam (Valium), alprazolam (Xanax), and estazolam (ProSom), are most commonly used to
treat anxiety, acute stress reactions, panic attacks, convulsions, and sleep disorders. They are
usually prescribed only for short-term relief of sleep problems due to the risk of developing
tolerance and addiction. Newer sleep medications, such as zolpidem (Ambien) and eszopiclone
(Lunesta), are now more commonly prescribed to treat sleep disorders as they act on a subset of
the receptors in the brain, lowering the risk for abuse and addiction (NIDA, 2009).
Most of the CNS depressants enhance the actions of the neurotransmitter gammaaminobutyric acid (GABA), which works by decreasing brain activity. Although the classes of
CNS depressants work in different ways, it is ultimately their ability to increase GABA activity
that produces a calming or drowsy effect (NIDA, 2009).
Benzodiazepines are the most widely used anxiolytic medications due to their wellestablished efficacy in the treatment of anxiety disorders. There has been a recent increase in the
U.S. prescription rates for benzodiazepines in general and for benzodiazepine anxiolytics among
youths 20 years and younger specifically. An increase in prescription rates may increase the
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likelihood that these medications will be misused for their calming effects (NIDA, 2009;
McCabe, 2005).
Overdose of CNS depressants can cause severe breathing problems and potentially lead
to death, particularly when these drugs are combined with other medications or alcohol (NIDA,
2009). The Drug Abuse Warning Network (DAWN), recently found benzodiazepines to be one
of the most frequently reported prescription medications in emergency room drug-abuse related
cases. According to DAWN data, emergency department mentions of benzodiazepines
significantly increased (38%) between 1995 and 2002. In particular, mentions of alprazolam
(Xanax) increased 62% and mentions of clonazepam (Klonopin) increased 33% over a similar
time frame (McCabe, 2005)
National epidemiological studies, national surveillance reports, and college-based studies
provide strong evidence that the nonmedical use of prescription benzodiazepine anxiolytics is
increasing among young adults and college students. The Harvard School of Public Health
College Alcohol Study (CAS) reported that the past year nonmedical use of benzodiazepine
anxiolytics more than doubled between 1993 and 2001 (1.8% and 4.5%, respectively) in the past
decade among U.S. college students (McCabe, 2005). Recent studies indicate that the
nonmedical use of prescription benzodiazepine anxiolytics among college students is at its
highest level in the past two decades, with 1 in every 10 college students report nonmedical use
of these drugs in their lifetime (McCabe, 2005).
Opioids
Opioids, also known as prescription narcotics or pain killers, are prescribed for their
effective pain-relieving qualities. Commonly prescribed opioids include morphine (e.g., Kadian,
Avinza), codeine, and oxycodone (e.g., OxyContin, Percodan, Percocet). Opioids affect the
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brain and body by attaching to proteins called opioid receptors, found in the brain, spinal cord,
and gastrointestinal tract. Once attached, these drugs can block the perception of pain. Side
effects of opioids include drowsiness, nausea, constipation, and, depending upon the amount
taken, depress respiration (NIDA, 2009).
Nonmedical use of opioids is common because if their euphoric effects which impact the
regions of the brain that perceive pleasure. Euphoric effects are often intensified when
administered by routes other than those recommended, such as snorting or injecting. This also
increases the risk for serious medical consequences, such as opioid overdose (NIDA, 2009).
When taken as directed, opioids can be used to manage pain effectively; however longterm use of opioids can lead to physical dependence and addiction (NIDA, 2009). Opioid-based
medications may cause abnormally slow speech, reaction time, and movements, as well as
confusion and disorientation. Abusers typically appear apathetic, lethargic, and/or sleepy.
Taking a large single dose of an opioid may result in severe respiratory depression which can
lead to death (NIDA, 2009).
Currently, approximately 1 in every 10 Americans between the ages of 18 and 25 report
the nonmedical use of opioid analgesics in the past year. Among four different classes of
psychotherapeutic drugs (opioid analgesics, tranquilizers, stimulants, and sedatives), opioid
analgesics was the class with the greatest nonmedical use, abuse, and dependence according to
the 2001 National Household Survey on Drug Abuse (McCabe, Teter, Boyd, Knight, &
Wechsler, 2005a).
The 2002 National Survey on Drug Use and Health found that more than half (55%) of
admissions to emergency departments involved prescription narcotics (Hamilton, 2009). In
addition, the 2006 DAWN data indicated that the overall mention of opioid analgesics
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combinations by emergency departments significantly increased from 1995 to 2002 by 163%.
Emergency department visits naming hydrocodone combinations also increased 160% in 2002
with hydrocodone the most commonly reported pain reliever (McCabe et al., 2005a).
Numerous studies have been published reporting the growing trends of prescription
opioid use on college campuses, with lifetime prevalence of use around 12% and past year
prevalence around 7% (McCabe et al., 2005a). The life-threatening side effects associated with
opioid use provide strong rationale for public health professionals to understand the reasons and
patterns associated with use (Hamilton, 2009).
Stimulants
Stimulants are frequently prescribed to increase alertness, attention, and energy.
Stimulants have been used to treat a variety of disorders including asthma, obesity, and
neurological disorders, however, as their potential for abuse and addiction became increasingly
evident, the medical use of stimulants began to decline. Currently, stimulants are prescribed for
the treatment of only a few health conditions, including narcolepsy, depression, and most
notably, ADHD (NIDA, 2009).
Stimulants, such as dextroamphetamine (e.g., Dexedrine and Adderall) and
methylphenidate (e.g., Ritalin and Concerta) resemble the chemical structures of the brain
neurotransmitter monoamines, which includes norepinephrine and dopamine. Stimulants
enhance the effects of these neurotransmitters in the brain, which is often associated with a sense
of euphoria. However, stimulants also increase blood pressure and heart rate, and constrict blood
vessels (NIDA, 2009).
Adverse effects of stimulants include headaches, anxiety, anorexia, gastrointestinal
distress, and sleeping problems (Hamilton, 2009). Abusers appear to have boundless energy and
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may display irritability, paranoia, and anger with some reporting hallucinations in the form of
amphetamine psychosis (NIDA, 2009).
As with other drugs of abuse, it is possible to become dependent upon or addicted to
stimulants. Repeated use of stimulants over a short period can lead to feelings of hostility or
paranoia (NIDA, 2009). Prescriptive stimulants have a black box warning mandated by the U.S.
Food and Drug Administration because they can cause cardiovascular problems (Hamilton,
2009). Taking high doses of a stimulant may result in dangerously high body temperature and an
irregular heartbeat, with the potential for cardiovascular failure or lethal seizures (NIDA, 2009).
Studies have indicated a rise in the prescribing of psychoactive medications in the United
States, including amphetamines and other stimulant medications. This rise may be attributable to
increased awareness of the disorder. While these are effective treatments for ADHD, there is a
growing concern regarding the potential abuse of these medications. In a study by McCabe et
al., (2005b), approximately 6.9% of college students reported lifetime nonmedical use, with
4.1% reporting use in the past year (McCabe, Knight, Teter, & Wechsler, 2005b). Furthermore,
the Monitoring the Future Study reported higher rates of nonmedical Ritalin among college
students when compared to their peers not attending college (Substance Abuse and Mental
Health Services Administration [SAMHSA], 2009; McCabe et al., 2005b). College students
aged 18 to 22 were twice as likely as their counterparts (who were not full time college students)
to report past year nonmedical use of Adderall. They were also 5 times more likely to have used
prescription pain relievers nonmedically (SAMHSA, 2009).
Illicit use of prescription stimulants by college students is primarily through oral
administration. Motives of stimulant use most commonly reported were to help with
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concentration and alertness when studying. Reported less often were to get “high” and
experimentation (Hamilton, 2009).
Risk Factors for Abuse
Compared to the understanding of tobacco and alcohol use on college campuses,
knowledge on the risk factors and use of prescription drugs is lacking. The minimal
epidemiological research presents a need to accurately assess the characteristics of those
individuals most at risk for nonmedical use of prescription drugs (McCabe et al., 2005a). Recent
research has identified characteristics of collegiate nonmedical prescription CNS depressant,
opioid, and stimulant users, noting differences in race, gender, academic performance, and living
arrangement (McCabe et al., 2005a; McCabe et al., 2005b; McCabe, 2008). While many
characteristics are known, there remains a need to more accurately identify the risk factors and
trends associated with nonmedical use.
Race
Nonmedical prescription drug use has been found to vary among race/ethnicity. Recent
studies indicate that prescription drug use is much more prevalent among White students than
students of a different race or ethnicity. Specifically, nonmedical use of depressants was higher
among White college students. In addition, nonmedical use of prescription benzodiazepine
anxiolytics was less likely to occur among college students who were Asian, and Hispanic
(McCabe, 2005).
Studies also note racial differences among prescription opioid users. McCabe et al.,
(2005a) found that White students were over two times more likely than African-American and
Asian college students to report nonmedical use of prescription opioid analgesics. These higher
rates of nonmedical use found among White college students compared to other racial groups
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also parallel recent racial differences identified among high school seniors (McCabe et al.,
2005a).
Nonmedical stimulant use also varies by student’s race/ethnicity. White students were
more likely than Asian and African American students to report nonmedical use of stimulants in
both past year and past month prevalence (McCabe et al., 2005b).
Gender
The Monitoring the Future Report indicates that males are more likely to use most illicit
drugs, with the differences seeming to be largest at the higher frequency of use levels.
Specifically, gender differences in prescription drug abuse have been noted in various studies
(Johnston et al., 2009).
In a study by McCabe et al., (2005b), after adjusting for a number of predictors including
race, age, living arrangement, grade point average, college men were almost two times more
likely than women to report non-medical use of prescription stimulants. Furthermore,
experimentation with stimulants was reported as reason for abuse by 34.6% of men versus 18.2%
of women whereas women were more likely than men report using prescription stimulants to
lose weight, to help study, and to help increase alertness (Teter, McCabe, LaGrange, Cranford, &
Boyd, 2006).
Although the actual past-year prevalence for non-medical use of prescription opioids did
not differ by gender (men = 7.4% and women = 7.5%), undergraduate women perceived the
past-year prevalence to be significantly higher than their male counterparts (McCabe, 2008).
Academic Performance
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Prior research has indicated that college students often turn to illicit drugs and or alcohol
in response to stress in academic settings (Ford & Schroeder, 2008). Specifically, past year
depressant use varied significantly as a function of grade point average (GPA) (McCabe, 2005).
A 2005 study by McCabe et al. found that students who earned a B or lower were almost
two times more likely to report nonmedical use prescription opioids when compared to students
with higher grade point averages (McCabe et al., 2005a).
Furthermore, students who had a B or lower grade point average were almost two times
more likely to report nonmedical stimulant use when compared to students with a B+ average or
higher. Additional research has indicated that the most commonly reported motives for illicit
stimulant use were to concentrate (65.2%), help study (59.8%) and increase alertness (47.5%)
(Teter, et al., 2006).
Living Arrangement
A student’s living conditions can significantly impact the availability and perception of
substances. In a longitudinal study from 1997 to 2001, commuter status was significantly
associated with nonmedical prescription drug abuse (McCabe, West, & Wechsler, 2007).
Additionally, students residing in off-campus housing and fraternity and sorority houses
were almost two times more likely than students living on campus to use opioids nonmedically
(McCabe et al, 2005a).
Similarly, students living in a fraternity or sorority house were significantly more likely
to use stimulants when compared to students living in same-sex residence halls (McCabe et al.,
2005b).
Alcohol and other drug use
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Rates of prescription drug abuse are higher among students who use other substances
such as alcohol and marijuana, as well as those who engage in risky behaviors. The odds of
reporting use of 3,4-methylenedioxymethamphetamine (Ecstasy) was more than 14 times greater
among past-year nonmedical users of prescription drugs compared with college students who did
not use prescription drugs in the past year. The findings of this study provide compelling
evidence that nonmedical users of prescription drugs are at substantially higher risk of a positive
screening result for drug abuse (McCabe, 2008).
Nonmedical benzodiazepine anxiolytic users were over four times more likely than
students who had not used benzodiazepine anxiolytics nonmedically to report past month
cigarette use and frequent binge drinking in the past 2 weeks. Users were also over 10 times
more likely to report past month and past year use of cocaine, ecstasy, and prescription
stimulants. Most notably, nonmedical benzodiazepine anxiolytic users were over 30 times more
likely to report past year nonmedical use of prescription opioid analgesics (OR = 32.13,
p < 0.001) (McCabe, 2005).
Nonmedical prescription opioid users were over 4 times more likely to report frequent
binge drinking, over 8 times more likely to report marijuana use in the past year, and over 13
times more likely to report cocaine use in the past year. Furthermore, users were four times
more likely to report driving after binge drinking, and almost six times more likely to report
being a passenger with a drunk driver than college students who had not abused prescription
opioids. This is particularly concerning as opioids, even in small, monitored doses can have an
increased the risk of injury or medical emergency. Yet when combined with other drugs, such as
alcohol which is also a depressant, there is an increased risk for severe psychomotor impairment,
respiration depression, unconsciousness, and death (Garnier et al., 2009).

13

Nearly 90% of full-time college students who used Adderall nonmedically in the past
year were past month binge alcohol consumers, and more than 50% were heavy alcohol users
(SAMHSA, 2009). Nonmedical use of prescription stimulants is related to substance use and
risky behaviors. Students reporting nonmedical use of stimulants were 10 times more likely to
report marijuana use in the past year, 7 times more likely to be a binge drinker, and 20 times
more likely to report cocaine use (McCabe et al., 2005b).
Affiliation with a Fraternity/Sorority
Fraternity and sorority membership can play a significant role in a student’s perceptions
and access to substances, including prescription drugs. Previous research has noted that
nonmedical past month use of prescription benzodiazepine anxiolytics differed significantly as a
function of fraternity/sorority membership. Past-year non-medical use of prescription stimulants
was significantly more prevalent among fraternity/sorority members (12.0%) compared to nonmembers (5.0%). Similarly, fraternity/sorority members also perceived a higher rate of nonmedical prescription stimulant use compared to non-members (McCabe, 2008).
Restatement of Specific Aims
The purpose of this study is to examine risk factors for nonmedical prescription drug
abuse and their relationship with use of depressants, opioids, and stimulants. Virginia
Commonwealth University has not previously assessed prescription drug use among its students
therefore, this improved understanding will assist in the creation of effective health programs
aimed at preventing and reducing use on campus.
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METHODS
The purpose of this study is to conduct a secondary analysis of survey data collected
during February 2009 at Virginia Commonwealth University (VCU). The study population
consists of n = 1,417 randomly selected VCU undergraduate students in February 2009.
Study Design
The ACHA-NCHA II was approved by the institutional review board at a large, urban
university and was conducted during February 2009. A random sample of 5,238 undergraduate
and graduate students was drawn from a total population of 29,513. The random sample
received a letter notifying students of their selection for the study. The letter described the study
and informed students that they would soon receive an email that contained a self-administered
confidential web survey; similar methods have proved to be effective for conducting research on
alcohol and drug use among college students (Pealer, Weiler, Pigg, Miller, Forman, 2001).
Following the initial letter and email, nonrespondents were sent up to two reminder emails.
Participants were eligible to win prizes including a Nintendo Wii, Starbucks gift cards, and VCU
t-shirts. The final response rate was 36.4%.
Study Instrument
The American College Health Association-National College Health Assessment II
(ACHA-NCHA II) was used to survey students. The survey contains 65 multiple choice
questions on 8 content areas including: Health, Health Education, and Safety; Alcohol, Tobacco,
and Drugs; Sex Behavior and Contraception; Weight, Nutrition, and Exercise; Mental Health;
Physical Health; Impediments to Academic Performance; and also assesses demographic
characteristics. An additional 14 questions were added to assess VCU specific health promotion
campaigns and services.
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Demographics
Respondents were asked to provide demographic information, including their
race/ethnicity and gender.
Student Characteristics
Participant’s academic performance was assessed in the survey. Students were asked,
“What is your approximate cumulative grade point average,” with responses ranging from (1) A
to (5) N/A. Student’s living arrangement was also assessed with responses ranging from (1)
campus residence hall to (6) other. Student’s affiliation with a fraternity or a sorority was also
assessed.
Nonmedical use of prescription drugs
Respondents were asked, “Within the last 12 months, have you taken any of the
following prescription drugs that were not prescribed to you?” The scale included “No” and
“Yes” and listed sedatives (e.g., Xanax, Valium), pain killers (e.g., OxyContin, Vicodin,
Codeine), and stimulants (e.g., Ritalin, Adderall).
Alcohol Use
Alcohol use was assessed with the question, “Within the last 30 days, on how many days
did you use alcohol?” The response scale ranged from (1) Never used to (8) Used daily.
Respondents were also assessed on their alcohol consumption behaviors; “In the last two weeks
how often did you consume more than 5 drinks in one setting,” with responses ranging from (1)
N/A, don’t drink to (12) 10 or more times.
Other Drug Use
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Other drug use was assessed by past 30 day use of marijuana. Respondents answered the
question, “Within the last 30 days, on how many days did you use marijuana?” The response
scale ranged from (1) Never used to (8) Used daily.
Sample
The final sample included n = 1,417 undergraduate students. Only students who were 18
years or older are included in the sample. This sample was cleaned to only include
undergraduate students.
The mean age of the sample population was 21.62 years (SD = 5.13). Females
constituted 67.7% (n = 960) of the sample, compared to 31.6% (n = 448) of males. The majority
of the sample was White, non-Hispanic (67.2%, n = 952) followed by 14.8% (N = 210)
identifying as Black, non-Hispanic and 12.3% (n = 174) Asian or Pacific Islander. Almost all
survey participants were full time students (92.2%, n= 1,306). The majority of students
completing the survey lived off campus without their parents (49.8% n = 705) reflecting VCU’s
high commuter population. Students living in campus residence halls constituted 27% (n =382)
of the sample, and 17.1% (n = 242) lived off campus with a parent or guardian. Of the total
sample, 23.8% (n = 337) were first year students, 22.9% (n = 325) were second year students,
24.0% (n = 340) were third year and 19.9% (n = 282) were fourth year students.
Statistical Analysis
All statistical analyses were conducted using Predictive Analytics SoftWare (PASW)
Statistics version 18. Overall prevalence rates for lifetime and past-year illicit use of prescription
CNS depressant, opioid, and stimulant use were examined. Bivariate analyses were conducted
for each prescription drug and individual student characteristics (e.g., race, gender, academic
performance, living arrangement, use of alcohol and marijuana, and fraternity/sorority
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affiliation) using Pearson’s Chi-Square test of significance. Multiple logistic regressions were
used to examine the relationships between student characteristics and illicit use of each
prescription drug. Interactions between individual level characteristics and nonmedical
prescription drug use were also examined.
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RESULTS
Nonmedical Prescription Depressant Use by Student Characteristics
Approximately 4% (n = 57) of college students reported past year use of nonmedical
prescription CNS depressants. The average age of depressant users was 20.68 (SD = 2.45),
indicating that users were slightly younger than nonusers who averaged 21.61 years of age (SD =
5.12). White, non-Hispanic students constituted the largest percentage of users with 4.74 (n =
45) reporting nonmedical depressant use in the last year (See Table 1a). Approximately 4.49%
(n = 45) of male students were users, compared to 3.86% (n = 37) of females. Those living in off
campus or other housing constituted 4.84% (n = 34) and 5.8% (n = 4) respectively.
Differences among nonmedical prescription antidepressant users and student
characteristics (race, age, gender, academic performance (GPA), living arrangement, alcohol and
other drug usage, and affiliation with a fraternity/sorority) were assessed using Pearson’s χ2 test.
As illustrated in Table 2, past year use of prescription depressants differed significantly as a
function of residence (χ2 = 4.33, df = 1, p < 0.05), alcohol (χ2 = 20.43, df = 1, p < 0.05) and
marijuana use (χ2 = 33.33, df = 1, p < 0.05), and past 14-day binge drinking (χ2 = 6.76, df = 1, P
< 0.05). Race, gender, academic performance, and fraternity/sorority affiliation did not
significantly differ among users and nonusers of prescription CNS depressants.
Specifically, those who lived off campus were 2.12 times more likely to use CNS
depressants nonmedically when compared to students living on campus (95% CI = 1.03, 4.35).
Additionally, students who reported alcohol use were 4.26 times more likely to use depressants
compared to students who do not drink (95% CI = 1.32, 13.73). Students who used marijuana
(OR = 5.15, 95%CI = 2.79, 9.50) and reported an episode of binge drinking in the past 14 days
(OR = 3.58, 95% CI = 1.28, 9.98) were also more likely to use depressants (See Table 2).
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Multiple logistic regression analyses further indicated that college students who lived off
campus, used alcohol and marijuana in their lifetime was the best predictor of nonmedical
prescription depressant use (see Table 3). These students were 4.41 times more likely to use
depressants than students who lived on campus, and who did not consume alcohol or use
marijuana (95% CI = 2.28, 8.54).
Interactions between prescription CNS depressant users and nonusers and student
characteristics were examined. There were no statistically significant interactions for past year
prescription depressant use.
Nonmedical Prescription Opioid Use by Student Characteristics
Approximately 11.2% (n = 158) of college students reported past year use of nonmedical
prescription use of pain killers. As described in Table 1, the average age of users was 21.81 (SD
= 5.07) compared to nonusers which was 21.61 (SD = 5.12). Furthermore, 10.71% (n = 48) of
males reported prescription opioid use compared to 11.48% (n = 110) of females. White, nonHispanic students constituted 12.3% (n = 117) of users, compared to 10.95% (n = 23) of Black,
non-Hispanic students. Approximately 10.24% (n = 39) of students living in campus residence
halls, 12.36% (n = 87) of off-campus students and 15.49% (n = 11) of other non campus housing
students reported nonmedical use. Approximately 11.96% (n = 11) of part time students reported
nonmedical prescription opioid use, compared to 11.20% (n = 149) of full time students.
Differences among nonmedical prescription pain killer users and individual
characteristics (race, gender, academic performance (GPA), living arrangement, alcohol and
other drug usage, and affiliation with a fraternity/sorority) were assessed using Pearson’s χ2 test.
Differences among users and nonusers were found to be significant among Asian or
Pacific/Islanders compared to nonusers (χ2 = 8.50, df = 1, p < 0.05). Use also different
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significantly as a function of academic performance (χ2 = 4.80, df = 1, p < 0.05). Consistent
with the literature, opioids use differed significantly as a function of lifetime alcohol (χ2 = 12.34,
df = 1, p < 0.05) and marijuana use (χ2 = 59.99, df = 1, p < 0.05), and incidence of binge
drinking (χ2 = 69.72, df = 1, p < 0.05). Differences among characteristics such as gender,
residence, and fraternity or sorority affiliation were not found to be significant.
Asian or Pacific Islander students were less likely to use prescription opioids (OR = 0.35,
95% CI = (0.17, 0.73) compared to students of a different race/ethnicity (see Table 2). However,
students who earned a C or lower GPA (OR = 1.51, 95% CI = 1.04, 2.18), used alcohol (OR =
2.74, 95% CI = 1.53, 4.92) and marijuana (OR = 3.75, 95% CI = 2.64, 5.33), and those who
reported an episode of binge drinking in the past 14 days (OR = 2.74, 95% CI = 1.58, 4.73) were
more likely to use prescription opioids nonmedically.
However, multiple logistic regression analyses indicated that Asian or Pacific Islander
students who had a C or lower GPA and reported use of alcohol and marijuana was the best
predictor of nonmedical prescription opioid use (see Table 3). These students were 3.25 times
more likely to use prescription opioids when compared to other students (95% CI = 2.22, 4.78).
Interactions between student characteristics and nonmedical prescription opioids use
were examined however none were found to be significant.
Nonmedical Prescription Stimulant Use by Student Characteristics
Approximately 8.7% (n = 123) of students reported past year use of nonmedical
prescription use of stimulants. As noted in Table 1, the average age of nonmedical prescription
stimulant users was 20.85 (SD = 3.48) compared to 21.70 (SD = 5.27) of nonusers. Furthermore,
9.87% (n = 44) of male students reported use, compared to 8.25% (n = 79) of female students.
Approximately 10.33% (n = 98) of users in the sample were White, non-Hispanic, compared to
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12.07% (n = 7) of Hispanic students, and 3.81% (n = 8) of Black, non-Hispanic students.
Additionally, 11.14% (n = 78) of users reported living off campus with 8.99% (n = 117) enrolled
in the university full time.
Differences among nonmedical prescription stimulant users and student characteristics
(race, gender, academic performance (GPA), living arrangement, alcohol and other drug usage,
and affiliation with a fraternity/sorority) were assessed using Pearson’s χ2 test. Nonmedical
prescription stimulant users differed significantly among students reporting White, non-Hispanic
and African American, non-Hispanic race/ethnicity. Nonmedical users differed significantly
between students reporting A GPAs compared to those reporting B or lower averages (See Table
2). Nonmedical prescription stimulant users different significantly among students living on or
off campus, (χ2 = 4.73, df = 1, p <0.05) as well as those living with or without their parents (χ2 =
4.15, df = 1, p < 0.05). Consistent with the literature, use was found differ significantly as a
function alcohol use (χ2 = 23.10, df = 1, p < 0.05). Marijuana use and past 14 day incidence of
binge drinking were also noted to differ significantly among users (χ2 = 91.07, df = 1 p < 0.05)
and (χ2 = 20.46, df = 1, p < 0.05) respectively. Gender and fraternity/sorority affiliation were not
statistically significant.
White, non-Hispanic students were 2.02 times more likely to use prescription stimulants
(95% CI = 1.28, 3.18) compared to students of a different race/ethnicity (See Table 2).
However, Black, non-Hispanic students were less likely to use prescription stimulants (OR =
0.37, 95% CI = 0.18, 0.78). Students with a B or lower GPA were more likely to use stimulants
(OR = 1.93, 95% CI = 1.21, 3.08) compared to students earning an A average. Students living
off campus (OR = 1.66, 95% CI = 1.05, 2.64) and living off campus without their parents (OR =
1.84, 95% CI = 1.02, 3.32) were also more likely to use prescription stimulants. Alcohol users
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were 10.04 times more likely to use than non users (95% CI = 3.17, 31.83). Students reporting
marijuana use (OR = 6.94, 95% CI = 4.43, 10.86) and past 14 day binge drinking (OR = 5.52,
95% CI = 2.40, 12.75) were also more likely to use prescription stimulants nonmedically.
The best predictor of nonmedical prescription stimulant use was found to be among
students who were White, non-Hispanic, had B or lower grade point averages and reported
alcohol use (OR = 7.96, 95% CI = 2.50, 25.41) (see Table 3). Furthermore, students who lived
off campus without their parents and reported alcohol use were significantly more likely to use
prescription stimulants nonmedically (OR = 7.99, 95% CI = 2.51, 25.47).
Interactions were examined between the student characteristics investigated however
there were no statistically significant interactions for past year prescription stimulant use.
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DISCUSSION
This study found that the past year use of nonmedical prescription depressant, opioids,
and stimulant use was 4%, 11.2% and 8.7% respectively. These rates are similar to recent
studies conducted at other institutions (Garnier et al., 2009; McCabe et al., 2005a, McCabe et at.,
2005b). Nonmedical use was higher among certain college students, however characteristics
varied by type of drug. The student characteristics analyzed in this study provide several
implications for guiding prevention and intervention efforts as certain characteristics were
associated with an increased or decreased risk of nonmedical prescription drug use. More
importantly, this research suggests that prescription drug interventions should be uniquely
tailored as the student characteristics associated with use vary across each class of prescription
drug.
Specifically, interventions focusing on nonmedical prescription depressant should target
college students who live off campus, and have used alcohol or marijuana in their lifetime.
Interventions aimed at reducing opioid use should focus on students who have a C or lower
average and reported lifetime use of marijuana. Finally, nonmedical prescription stimulant
interventions should target students who are White, non-Hispanic with a B or lower grade point
average. Additionally, students who lived off campus, without their parents and reported alcohol
use were significantly more likely to use prescription stimulants nonmedically. Many of these
characteristics have been shown in previous studies to be associated with higher rates of
substance abuse (Garnier et al., 2009; McCabe et al., 2005a; McCabe et al., 2005b).
Consistent with previous studies, student’s race/ethnicity plays an important role in the
nonmedical use of prescription drugs. Stimulant use was found to be much higher among White,
non-Hispanic college students (McCabe et al., 2005b).
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Both prescription depressant and stimulant use was associated with student’s residence.
Students who lived off campus were more likely to use depressants and stimulants nonmedically.
In previous studies, commuter status was significantly associated with nonmedical prescription
drug abuse (McCabe, 2008). Additionally, students who lived off campus without their parents
were more likely to use stimulants. These findings are particularly significant, as the university
has a large commuter population therefore, interventions should be targeted towards this
population.
Prior research has indicated that college students often turn to illicit drugs or alcohol in
response to stress in academic settings (Ford & Schroder, 2008). These findings support
previous research as use of prescription opioids and stimulants varied significantly as a function
of academic performance. Students with a GPA of a C or lower were significantly more likely to
use opioids compared to students with a B or lower average who were more likely to use
prescription stimulants. This difference may be attributed to reasons for use such as to “get
high” compared to performance enhancement and should be investigated further to develop more
tailored interventions.
Alcohol and other drug use were significantly associated with all three types of
prescription drugs, supporting the findings of previous studies. Studies conducted at other
universities have documented higher rates of prescription drug abuse among students who use
other substances such as alcohol and marijuana, as well as those who engage in other risky
behaviors (Garnier, 2009; McCabe, 2005; McCabe, 2008). Furthermore, students who reported
binge drinking the past 14 days were significantly more likely to abuse prescription drugs. The
findings of this study provide compelling evidence that nonmedical users of prescription drugs
are at substantially higher risk of abusing other types of drugs.
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The Monitoring the Future Report indicates that males are more likely to use most illicit
drugs, with the differences seeming to be largest at the higher frequency of use levels (Johntston
et al., 2009). Contrary to this report, gender was not found to be significantly associated with
use of any of the prescription drugs examined in this study.
Additionally, fraternity or sorority affiliation was not significantly associated with drug
use. These findings may be a reflection of the low percentage of students involved in greek
organizations at this institution and require further investigation.
Limitations
Several limitations prevent conclusive interpretation of the study findings. The ACHANCHA II consists of data from a web-based survey emailed to participants; therefore the findings
are subject to the limitations of self-report surveys. The survey attempted to minimize the bias
typically associated with self-report surveys instituting certain procedures that past research has
shown improves the validity and reliability of substance use data collected via self-report
surveys, including informing the student that participation was voluntary, ensuring anonymity
and explaining the relevance of the study. Furthermore, research has documented the
effectiveness of web-based surveys for college populations (Pealer et al., 2001).
The data analyzed were cross-sectional; therefore inferences about the temporal sequence
of causality between student characteristics and nonmedical prescription drug use could not be
established. Furthermore, cross-sectional surveys are often prone to selection bias. Although the
response rate was adequate for college surveys, selection bias may impact the interpretation of
the findings as there may be inherent differences among students who did and did not elect to
complete the survey. While selection bias cannot be fully moved, the sample analyzed closely
matched the demographics of the university, reliving concerns regarding non-response.
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The sample size for this study was particularly small. A small sample size has a greater
probability that the observation was coincidentally particularly good or particularly bad.
Therefore it is difficult to find significant relationships from the data, as statistical tests typically
require a larger sample size to justify that the effect was not due to chance alone. As such, it is
important not to make strong conclusions about the risk factors identified in this study whether
the results were positive or not. However, data from this study should be used to design larger
confirmatory studies.
Although rates of nonmedical use were consistent with other findings, additional research
is needed in diverse settings in order to assess the generality of the findings. It is important for
individual institutions to assess prescription drug use among their student population in order to
create the most effective and appropriate interventions.
Despite these limitations, this study provides a clear understanding of the overall use of
nonmedical prescription drugs on campus, as well as identified student characteristics that may
be useful in future research and interventions. Though research exists documenting motives for
use, future analysis should investigate these factors at this particular institution to obtain a more
accurate and reliable understanding of prescription drug abuse on campus.
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CONCLUSION
As prescription drug abuse rates continue to rise among college students, it is imperative
that universities identify characteristics and associations with use in order to reduce harm on
campus. The information presented in this research will help guide the development of effective
wellness programs designed to reduce the usage of prescription drug abuse. This study provides
valuable information for university administration and health education staff alike. The results
from this study will be useful in developing targeted and tailored interventions for prescription
drug abuse. The characteristics associated with prescription drug use will help guide health
promotion campaign decisions.
As a result of this research, the 2010 survey was modified to include more specific
questions regarding student’s perceptions of prescription drug abuse on campus, specifically on
depressants, opioids, and stimulants. Combined with the findings of this study, future research
on the impacts of student perceptions and usage may be investigated to implement prescription
drug abuse into an existing social norms campaign.
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Table 1a: Nonmedical Prescription CNS Depressant Users and Nonusers by
Student Characteristics
Users
NonUsers
Mean
SD
Mean
SD
Age
20.68
2.45
21.61
5.12
N
Row %
N
Row %
Race/Ethnicity
White, non-Hispanic
45
4.74%
905
95.26%
Black, non-Hispanic
4
1.91%
205
98.09%
Hispanic or Latino/a
2
3.45%
56
96.55%
Asian or Pacific Islander
6
3.47%
167
96.53%
AI, Alaskan Native, or Native Hawaiian
1
5.88%
16
94.12%
Biracial or Multiracial
1
1.75%
56
98.25%
Other
2
6.25%
30
93.75%
Gender
Male
20
4.49%
425
95.51%
Female
37
3.86%
922
96.14%
Academic Performance
A
15
3.63%
398
96.37%
B
26
3.87%
645
96.13%
C
15
5.02%
284
94.98%
D/F
1
6.67%
14
93.33%
N/A
0
0.00%
12
100.00%
Residence
Campus residence hall
9
2.36%
373
97.64%
Fraternity or sorority house
1
50.00%
1
50.00%
Other college/university housing
0
0.00%
11
100.00%
Parent/guardian's home
9
3.72%
233
96.28%
Other off-campus housing
34
4.84%
669
95.16%
Other
4
5.80%
65
94.20%
Year in School
1st year undergraduate
18
5.34%
319
94.66%
2nd year undergraduate
10
3.08%
315
96.92%
3rd year undergraduate
8
2.37%
330
97.63%
4th year undergraduate
13
4.63%
268
95.37%
5th year or more undergraduate
8
6.06%
124
93.94%
Enrollment Status
Full time
55
4.22%
1249
95.78%
Part time
2
2.22%
88
97.78%
Other
0
0.00%
13
100.00%
Fraternity or sorority member
Yes
5
4.67%
102
95.33%
No
52
4.04%
1236
95.96%
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Table 1b: Nonmedical Prescription Opioid Users and Nonusers by Student
Characteristics
Users
NonUsers
Mean
SD
Mean
SD
Age
21.81
5.07
21.6
5.14
N
Row %
N
Row %
Race/Ethnicity
White, non-Hispanic
117
12.30%
834
87.70%
Black, non-Hispanic
23
10.95%
187
89.05%
Hispanic or Latino/a
5
8.62%
53
91.38%
Asian or Pacific Islander
8
4.62%
165
95.38%
AI, Alaskan Native, or Native Hawaiian
2
11.76%
15
88.24%
Biracial or Multiracial
4
7.02%
53
92.98%
Other
4
10.00%
36
90.00%
Gender
Male
48
10.71%
400
89.29%
Female
110
11.48%
848
88.52%
Academic Performance
A
39
9.40%
376
90.60%
B
72
10.73%
599
89.27%
C
43
14.38%
256
85.62%
D/F
3
20.00%
12
80.00%
N/A
1
8.33%
11
91.67%
Residence
Campus residence hall
39
10.24%
342
89.76%
Fraternity or sorority house
0
0.00%
2
100.00%
Other college/university housing
0
0.00%
11
100.00%
Parent/guardian's home
21
8.68%
221
91.32%
Other off-campus housing
87
12.36%
617
87.64%
Other
11
15.49%
60
84.51%
Year in School
1st year undergraduate
35
10.42%
301
89.58%
2nd year undergraduate
40
12.35%
284
87.65%
3rd year undergraduate
31
9.12%
309
90.88%
4th year undergraduate
36
12.77%
246
87.23%
5th year or more undergraduate
16
12.03%
117
87.97%
Enrollment Status
Full time
146
11.20%
1158
88.80%
Part time
11
11.96%
81
88.04%
Other
0
0.00%
13
100.00%
Fraternity or sorority member
Yes
12
11.21%
95
88.79%
No
110
8.55%
1177
91.45%
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Table 1c: Nonmedical Prescription Stimulant Users and Nonusers by
Student Characteristics
Users
NonUsers
Mean
SD
Mean
SD
Age
20.85
3.48
21.7
5.27
N
Row %
N
Row %
Race/Ethnicity
White, non-Hispanic
98
10.33%
851
89.67%
Black, non-Hispanic
8
3.81%
202
96.19%
Hispanic or Latino/a
7
12.07%
51
87.93%
Asian or Pacific Islander
13
7.56%
159
92.44%
AI, Alaskan Native, or Native Hawaiian
1
5.88%
16
94.12%
Biracial or Multiracial
6
10.53%
51
89.47%
Other
7
17.50%
33
82.50%
Gender
Male
44
9.87%
402
90.13%
Female
79
8.25%
878
91.75%
Academic Performance
A
23
5.56%
391
94.44%
B
64
9.57%
605
90.43%
C
34
11.37%
265
88.63%
D/F
2
13.33%
13
86.67%
N/A
0
0.00%
12
100.00%
Residence
Campus residence hall
23
6.02%
359
93.98%
Fraternity or sorority house
1
100.00%
0
0.00%
Other college/university housing
1
9.09%
10
90.91%
Parent/guardian's home
13
5.37%
229
94.63%
Other off-campus housing
78
11.14%
622
88.86%
Other
7
9.86%
64
90.14%
Year in School
1st year undergraduate
27
8.06%
308
91.94%
2nd year undergraduate
29
8.92%
296
91.08%
3rd year undergraduate
27
7.96%
312
92.04%
4th year undergraduate
28
9.96%
253
90.04%
5th year or more undergraduate
12
9.09%
120
90.91%
Enrollment Status
Full time
117
8.99%
1185
91.01%
Part time
6
6.52%
86
93.48%
Other
0
0.00%
12
100.00%
Fraternity or sorority member
Yes
12
11.21%
95
88.79%
No
110
38.33%
177
61.67%
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Table 2: Bivariate Analyses: Student Characteristics and Nonmedical
Prescription Drug Use
χ2

p-value

OR

95% CI

Nonmedical CNS Depressant Use
Residence
Off-campus housing 4.33
<0.05
2.12
(1.03, 4.35)
Alcohol and Other Drug Use
Lifetime alcohol use 20.43
<0.05
4.26
(1.32, 13.73)
Lifetime marijuana use 33.33
<0.05
5.15
(2.79, 9.50)
Past 14-day binge drinking 6.76
<0.05
3.58
(1.28, 9.98)
Nonmedical Opioid Use
Race
Asian or Pacific Islander
8.50
<0.05
0.35
(0.17, 0.73)
Academic Performance
C or lower average 4.80
<0.05
1.51
(1.04, 2.18)
Alcohol and Other Drug Use
Lifetime alcohol use 12.34
<0.05
2.74
(1.53, 4.92)
Lifetime marijuana use 59.99
<0.05
3.75
(2.64, 5.33)
Past 14-day binge drinking 69.72
<0.05
2.74
(1.58, 4.73)
Nonmedical Stimulant Use
Race
White, non-Hispanic 9.50
<0.05
2.02
(1.28, 3.18)
Black, non-Hispanic 7.45
<0.05
0.37
(0.18, 0.78)
Academic Performance
B or lower average 7.74
<0.05
1.93
(1.21, 3.08)
Residence
Off-campus housing 4.73
<0.05
1.66
(1.05, 2.64)
Does not live with parents 4.15
<0.05
1.84
(1.02, 3.32)
Alcohol or Other Drug Use
Lifetime alcohol use 23.10
<0.05
10.04 (3.17, 31.83)
Lifetime marijuana use 91.07
<0.05
6.94
(4.43, 10.86)
Past 14-day binge drinking 20.46
<0.05
5.52
(2.40, 12.75)
*The results for student characteristics that were not significantly associated (p >
0.05) with past year nonmedical use of prescription drugs are not shown.
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Table 3: Logistic Regression Analysis: Student Characteristics
and Nonmedical Prescription Drug Use
OR
95% CI
p-value
Nonmedical CNS Depressant Use
Residence
Off campus housing 2.12
(1.03, 4.35) <0.05
Alcohol and Other Drug Use
Lifetime alcohol use 3.91 (1.21, 12.64) <0.05
Lifetime marijuana use 4.41
(2.28, 8.54) <0.05
Nonmedical Opioid Use
Race
Asian or Pacific Islander 0.35
(0.17, 0.73) <0.05
Academic Performance
C or lower average 1.50
(1.03, 2.17) <0.05
Alcohol and Other Drug Use
Lifetime marijuana use 3.25
(2.22, 4.78) <0.05
Past 14-day binge drinking 1.65
(2.15, 4.67) <0.05
Nonmedical Stimulant Use
Race
White, non-Hispanic 2.02
(1.28, 3.30) <0.05
Academic Performance
B or lower average 2.06
1.28, 3.30
<0.05
Residence
Live without parents 2.00
(1.10, 3.63) <0.05
Alcohol and Other Drug Use
Lifetime alcohol use 7.96 (2.50, 25.41) <0.05
Lifetime marijuana use 5.04
(3.15, 8.07) <0.05
Race
Black, non-Hispanic 0.37
(0.18, 0.78) <0.05
Academic Performance
B or lower average 2.09
(1.30, 3.34) <0.05
Residence
Live without parents 1.96
(1.08, 3.55) <0.05
Alcohol and Other Drug Use
Lifetime alcohol use 8.79 (2.76, 27.96) <0.05
Lifetime marijuana use 5.05
(3.16, 8.07) <0.05
*The results for student characteristics that were not significantly
associated (p > 0.05) with past year nonmedical use of prescription
drugs are not shown.
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